166 related articles for article (PubMed ID: 22021694)
1. Response to intrathecal infusions of Depocyt® in secondary diffuse leptomeningeal gliomatosis. A case report.
Beauchesne P; Blonski M; Brissart H
In Vivo; 2011; 25(6):991-3. PubMed ID: 22021694
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
3. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
Craig C
Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal infiltration as the presenting manifestation of a malignant glioma.
Wheen LC; Anderson NE; Baker PC; Singh VK; Synek BJ
J Clin Neurosci; 2006 Feb; 13(2):298-301. PubMed ID: 16431108
[TBL] [Abstract][Full Text] [Related]
5. [Leptomeningeal gliomatosis. 2 clinicopathological cases].
Fayet G; Bertout-Lemercier C; Gugenheim M; Auffray E; Jardel-Bouissière J; Lacroix C; Cuillière P; Lhuillier de Cordoze M; Fève JR
Rev Neurol (Paris); 1994 Oct; 150(10):700-3. PubMed ID: 7792477
[TBL] [Abstract][Full Text] [Related]
6. [Phase I study of intrathecal chemotherapy with NS-101 for leptomeningeal carcinomatosis in Japan].
Nakagawa H; Tamura M; Fukushima Y; Majima S; Yamada K
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1799-805. PubMed ID: 18030013
[TBL] [Abstract][Full Text] [Related]
7. Primary diffuse multinodular leptomeningeal gliomatosis: case report and review of the literature.
Debono B; Derrey S; Rabehenoina C; Proust F; Freger P; Laquerrière A
Surg Neurol; 2006 Mar; 65(3):273-82; discussion 282. PubMed ID: 16488248
[TBL] [Abstract][Full Text] [Related]
8. [Meningeal gliomatosis--clinical features and results of treatment].
Arita N; Hayakawa T; Mogami H; Ushio Y
Gan No Rinsho; 1989 Sep; 35(11):1308-12. PubMed ID: 2478733
[TBL] [Abstract][Full Text] [Related]
9. Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults.
Alvarez de Eulate-Beramendi S; Rigau V; Taillandier L; Duffau H
J Neurosurg; 2014 Apr; 120(4):833-9. PubMed ID: 24286144
[TBL] [Abstract][Full Text] [Related]
10. Primary diffuse leptomeningeal gliomatosis mimicking a chronic inflammatory meningitis.
Ko MW; Turkeltaub PE; Lee EB; Gonatas NK; Volpe NJ; Moster ML; Galetta SL
J Neurol Sci; 2009 Mar; 278(1-2):127-31. PubMed ID: 19135216
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
Glantz MJ; LaFollette S; Jaeckle KA; Shapiro W; Swinnen L; Rozental JR; Phuphanich S; Rogers LR; Gutheil JC; Batchelor T; Lyter D; Chamberlain M; Maria BL; Schiffer C; Bashir R; Thomas D; Cowens W; Howell SB
J Clin Oncol; 1999 Oct; 17(10):3110-6. PubMed ID: 10506606
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of encapsulated sustained-release cytarabine.
Murry DJ; Blaney SM
Ann Pharmacother; 2000 Oct; 34(10):1173-8. PubMed ID: 11054987
[TBL] [Abstract][Full Text] [Related]
13. Primary spinal leptomeningeal gliomatosis presenting visual disturbance as the initial symptom: case report.
Kobayashi M; Hara K; Nakatsukasa M; Murase I; Toya S
Acta Neurochir (Wien); 1996; 138(4):480-1. PubMed ID: 8738401
[TBL] [Abstract][Full Text] [Related]
14. [Gliomatosis cerebri. Ante-mortem diagnosis].
Rivas E; Guzmán J; Mora-La Cruz E; Cardozo-Durán J
Invest Clin; 1995 Sep; 36(3):149-57. PubMed ID: 7548307
[TBL] [Abstract][Full Text] [Related]
15. [Neoplastic meningitis. Diagnosis and individualised therapy].
Strik H; Prömmel P
Nervenarzt; 2010 Feb; 81(2):229-41; quiz 242. PubMed ID: 20140544
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
[TBL] [Abstract][Full Text] [Related]
17. Diffuse leptomeningeal gliomatosis: report of three cases.
Whelan HT; Sung JH; Mastri AR
Clin Neuropathol; 1987; 6(4):164-8. PubMed ID: 3652562
[TBL] [Abstract][Full Text] [Related]
18. Aggressive treatment with complete remission in primary diffuse leptomeningeal gliomatosis--a case report.
Beauchesne P; Pialat J; Duthel R; Barral FG; Clavreul G; Schmitt T; Laurent B
J Neurooncol; 1998 Apr; 37(2):161-7. PubMed ID: 9524095
[TBL] [Abstract][Full Text] [Related]
19. Primary leptomeningeal gliomatosis: case report and review of the literature.
Riva M; Bacigaluppi S; Galli C; Citterio A; Collice M
Neurol Sci; 2005 Jun; 26(2):129-34. PubMed ID: 15995830
[TBL] [Abstract][Full Text] [Related]
20. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
Jaeckle KA; Batchelor T; O'Day SJ; Phuphanich S; New P; Lesser G; Cohn A; Gilbert M; Aiken R; Heros D; Rogers L; Wong E; Fulton D; Gutheil JC; Baidas S; Kennedy JM; Mason W; Moots P; Russell C; Swinnen LJ; Howell SB
J Neurooncol; 2002 May; 57(3):231-9. PubMed ID: 12125986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
